Literature DB >> 28745482

Near-Infrared Triggered Upconversion Polymeric Nanoparticles Based on Aggregation-Induced Emission and Mitochondria Targeting for Photodynamic Cancer Therapy.

Yue Guan1, Hongguang Lu1, Wei Li1, Yadan Zheng1, Zhu Jiang1, Jialing Zou1, Hui Gao1.   

Abstract

Photodynamic therapy (PDT) is an auspicious strategy for cancer therapy by yielding reactive oxygen species (ROS) under light irradiation. Here, we have developed near-infrared (NIR) triggered polymer encapsulated upconversion nanoparticles (UCNPs) based on aggregation-induced emission (AIE) characteristics and mitochondria target ability for PDT. The coated AIE polymer as a photosensitizer can be photoactivated by the up-converted energy of UCNPs upon 980 nm laser irradiation, which could generate ROS efficiently in mitochondria and induce cell apoptosis. Moreover, a "sheddable" poly(ethylene glycol) (PEG) layer was easily conjugated at the surface of NPs. The pH-responsive PEG layer shields the surface positive charges and shows stronger protein-resistance ability. In the acidic tumor environment, PEGylated NPs lose the PEG layer and show the mitochondria-targeting ability by responding to tumor acidity. A cytotoxicity study indicated that these NPs have good biocompatibility in the dark but exert severe cytotoxicity to cancer cells, with only 10% cell viability, upon being irradiated with an NIR laser. The AIE nanoparticles are a good candidate for effective mitochondria targeting photosensitizer for PDT.

Entities:  

Keywords:  aggregation-induced emission; cancer cells; mitochondria; photodynamic therapy; upconversion nanoparticles

Mesh:

Substances:

Year:  2017        PMID: 28745482     DOI: 10.1021/acsami.7b07768

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  12 in total

Review 1.  Recent progress in development and applications of second near-infrared (NIR-II) nanoprobes.

Authors:  Jongyoon Shinn; Sunyoung Lee; Hyon Kyong Lee; Jaeeun Ahn; Seon Ah Lee; Seonju Lee; Yonghyun Lee
Journal:  Arch Pharm Res       Date:  2021-02-04       Impact factor: 4.946

Review 2.  Recent advances in nanoparticle carriers for photodynamic therapy.

Authors:  Gawon Yi; Suk Ho Hong; Jihwan Son; Jihye Yoo; Changhee Park; Yongdoo Choi; Heebeom Koo
Journal:  Quant Imaging Med Surg       Date:  2018-05

3.  Aromatic Thioacetal-Bridged ROS-Responsive Nanoparticles as Novel Gene Delivery Vehicles.

Authors:  Guo-Qing Lin; Wen-Jing Yi; Qiang Liu; Xue-Jun Yang; Zhi-Gang Zhao
Journal:  Molecules       Date:  2018-08-17       Impact factor: 4.411

4.  Mitochondria-Targeted Artificial "Nano-RBCs" for Amplified Synergistic Cancer Phototherapy by a Single NIR Irradiation.

Authors:  Liang Zhang; Dong Wang; Ke Yang; Danli Sheng; Bin Tan; Zhigang Wang; Haitao Ran; Hengjing Yi; Yixin Zhong; Han Lin; Yu Chen
Journal:  Adv Sci (Weinh)       Date:  2018-05-21       Impact factor: 16.806

Review 5.  Functional Polymer Nanocarriers for Photodynamic Therapy.

Authors:  Tuanwei Li; Lifeng Yan
Journal:  Pharmaceuticals (Basel)       Date:  2018-11-30

6.  Construction of biocompatible bovine serum albumin nanoparticles composed of nano graphene oxide and AIEgen for dual-mode phototherapy bacteriostatic and bacterial tracking.

Authors:  Yongxin Zhang; Hao Fu; De-E Liu; Jinxia An; Hui Gao
Journal:  J Nanobiotechnology       Date:  2019-10-10       Impact factor: 10.435

Review 7.  Improving the Phototherapeutic Efficiencies of Molecular and Nanoscale Materials by Targeting Mitochondria.

Authors:  Fengming Lin; Yan-Wen Bao; Fu-Gen Wu
Journal:  Molecules       Date:  2018-11-18       Impact factor: 4.411

8.  Near-infrared light-regulated cancer theranostic nanoplatform based on aggregation-induced emission luminogen encapsulated upconversion nanoparticles.

Authors:  Guorui Jin; Rongyan He; Qian Liu; Min Lin; Yuqing Dong; Kai Li; Ben Zhong Tang; Bin Liu; Feng Xu
Journal:  Theranostics       Date:  2019-01-01       Impact factor: 11.556

9.  Theranostic nanobubble encapsulating a plasmon-enhanced upconversion hybrid nanosystem for cancer therapy.

Authors:  Wen-Tse Huang; Ming-Hsien Chan; Xueyuan Chen; Michael Hsiao; Ru-Shi Liu
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

Review 10.  Recent progress in the development of upconversion nanomaterials in bioimaging and disease treatment.

Authors:  Gaofeng Liang; Haojie Wang; Hao Shi; Haitao Wang; Mengxi Zhu; Aihua Jing; Jinghua Li; Guangda Li
Journal:  J Nanobiotechnology       Date:  2020-10-29       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.